64 related articles for article (PubMed ID: 10083979)
1. Biochemical activities of extracts from Hypericum perforatum L. 3rd Communication: modulation of peroxidase activity as a simple method for standardization.
Schempp H; Denke A; Mann E; Schneider W; Elstner EF
Arzneimittelforschung; 1999 Feb; 49(2):115-9. PubMed ID: 10083979
[TBL] [Abstract][Full Text] [Related]
2. Biochemical activities of extracts from Hypericum perforatum L. 2nd Communication: inhibition of metenkephaline- and tyrosine-dimerization.
Denke A; Schneider W; Elstner EF
Arzneimittelforschung; 1999 Feb; 49(2):109-14. PubMed ID: 10083978
[TBL] [Abstract][Full Text] [Related]
3. Biochemical activities of extracts from Hypericum perforatum L. 4th Communication: influence of different cultivation methods.
Denke A; Schempp H; Mann E; Schneider W; Elstner EF
Arzneimittelforschung; 1999 Feb; 49(2):120-5. PubMed ID: 10083980
[TBL] [Abstract][Full Text] [Related]
4. Biochemical activities of extracts from Hypericum perforatum L. 1st Communication: inhibition of dopamine-beta-hydroxylase.
Kleber E; Obry T; Hippeli S; Schneider W; Elstner EF
Arzneimittelforschung; 1999 Feb; 49(2):106-9. PubMed ID: 10083977
[TBL] [Abstract][Full Text] [Related]
5. Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids.
Denke A; Schempp H; Weiser D; Elstner EF
Arzneimittelforschung; 2000 May; 50(5):415-9. PubMed ID: 10858868
[TBL] [Abstract][Full Text] [Related]
6. Characterization of supercritical fluid extracts of St. John's wort (Hypericum perforatum L.) by HPLC-MS and GC-MS.
Seger C; Römpp H; Sturm S; Haslinger E; Schmidt PC; Hadacek F
Eur J Pharm Sci; 2004 Mar; 21(4):453-63. PubMed ID: 14998575
[TBL] [Abstract][Full Text] [Related]
7. High performance liquid chromatography/electrospray mass spectrometry of Hypericum perforatum extracts.
Mauri P; Pietta P
Rapid Commun Mass Spectrom; 2000; 14(2):95-9. PubMed ID: 10623936
[TBL] [Abstract][Full Text] [Related]
8. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
9. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
[TBL] [Abstract][Full Text] [Related]
10. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry.
Tolonen A; Uusitalo J; Hohtola A; Jalonen J
Rapid Commun Mass Spectrom; 2002; 16(5):396-402. PubMed ID: 11857723
[TBL] [Abstract][Full Text] [Related]
11. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
12. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver.
Dostalek M; Pistovcakova J; Jurica J; Tomandl J; Linhart I; Sulcová A; Hadasova E
Life Sci; 2005 Dec; 78(3):239-44. PubMed ID: 16125735
[TBL] [Abstract][Full Text] [Related]
13. Comparative chemical composition and variability of biological activity of methanolic extracts from Hypericum perforatum L.
Conforti F; Statti GA; Tundis R; Bianchi A; Agrimonti C; Sacchetti G; Andreotti E; Menichini F; Poli F
Nat Prod Res; 2005 Apr; 19(3):295-303. PubMed ID: 15702645
[TBL] [Abstract][Full Text] [Related]
14. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
Schwarz D; Kisselev P; Roots I
Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
[TBL] [Abstract][Full Text] [Related]
16. St. John's wort - an overview.
Linde K
Forsch Komplementmed; 2009 Jun; 16(3):146-55. PubMed ID: 19657198
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
Schempp CM; Winghofer B; Müller K; Schulte-Mönting J; Mannel M; Schöpf E; Simon JC
Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro.
Winkler C; Wirleitner B; Schroecksnadel K; Schennach H; Fuchs D
Biol Chem; 2004 Dec; 385(12):1197-202. PubMed ID: 15653434
[TBL] [Abstract][Full Text] [Related]
19. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
Güzelcan Y; Scholte WF; Assies J; Becker HE
Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
